Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets

International Journal of Molecular Sciences
Rune KleppeFrode Selheim

Abstract

Platelet activation contributes to normal haemostasis but also to pathologic conditions like stroke and cardiac infarction. Signalling by cGMP and cAMP inhibit platelet activation and are therefore attractive targets for thrombosis prevention. However, extensive cross-talk between the cGMP and cAMP signalling pathways in multiple tissues complicates the selective targeting of their activities. We have used mathematical modelling based on experimental data from the literature to quantify the steady state behaviour of nitric oxide (NO)/cGMP/cAMP signalling in platelets. The analysis provides an assessment of NO-induced cGMP synthesis and PKG activation as well as cGMP-mediated cAMP and PKA activation though modulation of phosphodiesterase (PDE2 and 3) activities. Both one- and two-compartment models of platelet cyclic nucleotide signalling are presented. The models provide new insight for understanding how NO signalling to cGMP and indirectly cAMP, can inhibit platelet shape-change, the initial step of platelet activation. Only the two-compartment models could account for the experimental observation that NO-mediated PKA activation can occur when the bulk platelet cAMP level is unchanged. The models revealed also a potential for ...Continue Reading

References

Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M EndresJ K Liao
Apr 6, 2000·American Journal of Physiology. Heart and Circulatory Physiology·P HeF E Curry
Nov 14, 2001·Biochemical Pharmacology·U R SchwarzM Eigenthaler
Feb 27, 2003·The Journal of Cell Biology·Florian MullershausenDoris Koesling
Mar 6, 2003·The Biochemical Journal·Jun KoteraSharron H Francis
Jan 13, 2004·Physiological Reviews·Kjetil Taskén, Einar Martin Aandahl
Apr 13, 2004·The Journal of Biological Chemistry·Elaine MoJohn Garthwaite
Feb 5, 2005·The Journal of Biological Chemistry·Kristin VisteStein O Døskeland
May 12, 2005·American Journal of Physiology. Endocrinology and Metabolism·Hisham S Elbatarny, Donald H Maurice
Feb 16, 2006·The FEBS Journal·Nils BlüthgenBoris N Kholodenko
May 3, 2006·Circulation·Liliana R V CastroRodolphe Fischmeister
Aug 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Brijesh Roy, John Garthwaite
Aug 22, 2006·American Journal of Physiology. Heart and Circulatory Physiology·René WörnerJörg W Wegener
Oct 13, 2006·Bioinformatics·Stefan HoopsUrsula Kummer
Feb 13, 2007·Biophysical Journal·Radu V IancuRobert D Harvey
Mar 3, 2007·The Journal of Biological Chemistry·Simone Kobe de OliveiraAlbert P Smolenski
Apr 3, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hyung-Hwan KimJames K Liao
May 9, 2008·The Journal of Biological Chemistry·Brijesh RoyJohn Garthwaite
Sep 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Lindsay S WilsonDonald H Maurice
Apr 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ermanno PuxedduMartha Vaughan
May 6, 2009·The American Journal of Medicine·Carl J Pepine
Apr 29, 2009·Methods in Molecular Biology·Pedro MendesUrsula Kummer
Jul 16, 2009·Nitric Oxide : Biology and Chemistry·Catherine N Hall, John Garthwaite
Jul 17, 2009·The Journal of Biological Chemistry·Edward J HalveyJohn Garthwaite
Jul 28, 2009·The Journal of Biological Chemistry·Corina RusswurmMichael Russwurm

❮ Previous
Next ❯

Software Mentioned

LSODA
COPASI

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.